Stratum Nutrition named exclusive North American distributor for Korean oral probiotics range

By Stephen Daniells

- Last updated on GMT

© Delmaine Donson / Getty Images
© Delmaine Donson / Getty Images
OraTicx, a specialist in advanced oral probiotics based in Korea, has named Missouri-based Stratum Nutrition as its exclusive North American distributor for its oral probiotic formulations.

The agreement covers OraTicx's live strains oraCMU (Weissella cibaria​ CMU) and oraCMS1 (Weissella cibaria​ CMS1), as well as the postbiotic form of oraCMU.

"OraTicx's high-quality oral probiotics will further strengthen our portfolio of clinically proven ingredients,” said Micah Osborne, CEO of Stratum Nutrition. “We are pleased to offer more diverse and effective health solutions to North American consumers in both human and pet markets through this partnership."

According to Global Market Insights, the oral probiotic market was valued at US $2.5 billion in 2022 and is anticipated to register a CAGR of over 6.5% between 2023 and 2032, possibly reaching $4.8 billion. 

Science

OraTicx strains are reported to be supported by multiple published human clinical trials that show oraCMU’s ability to benefit oral microbiome balance while promoting dental health and fresh breath. 

A 2023 paper in Frontiers in Microbiology​ reported on findings from a randomized, double-blind, placebo-controlled clinical trial that included 100 adults with halitosis. The participants chewed a tablet containing OraCMU once a day for eight weeks, with the data showing that the probiotic led to significant improvements in their breath scores and a reduced presence of compounds that produce bad breath.

Similar effects are also reported in two canine clinical trials, according to a press release from Stratum.

Weissella cibaria​ CMS1 (oraCMS1) is supported by data from a randomized, double-blind, placebo-controlled, parallel trial with 90 healthy subjects, which found that 12 weeks of supplementation led to significant improvements in both the oral environment and immune function (Food & Function​, 2024​).

The postbiotic form of oraCMU shows promising mechanism of action in vitro​, added Stratum.

Combined expertise

"This exclusive distribution agreement with Stratum Nutrition is an important opportunity for us to introduce our innovative oral probiotics to North American consumers,” said Eun-Seop Yoon, CEO of OraTicx. “By combining the expertise of both companies, we will create new value in the North American health functional food market and grow into a global leading company that contributes to a healthy life."

Stratum’s existing product portfolio already includes microbiome modulation ingredients such as Bimuno GOS prebiotic and LBiome Lactobacillus LB postbiotic.

Related news

Related products

show more

Gut and mental health struggles affect consumers

Gut and mental health struggles affect consumers

Content provided by Verb Biotics | 23-Sep-2024 | White Paper

Verb Biotics, a biotech company focused on improving health through the gut microbiome, recently completed its second annual consumer survey to assess...

Explore Probiotic Adventure in Weight Management

Explore Probiotic Adventure in Weight Management

Content provided by CJ BIO | 02-Sep-2024 | White Paper

Curious about how you can deliver standout solutions? Dive into our trend report for valuable insights into current weight management market trends and...

Related suppliers

Follow us

Products

View more

Webinars